These studies have revealed the extensive tumour and immune ecosystems in primary breast cancers104,105 and highlighted associations between genomic alterations such as TP53 mutations and distinct epithelial and stromal phenotypes, that hypoxic environments may induce immune tolerance, and identified that single-cell pathology subgroups have distinct clinical outcomes104,105. Here, TP53 is linked to neoplasm.